Elevation Oncology (ELEV) Earnings Date & Reports

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ELEV is expected to report earnings to rise 9.33% to -19 cents per share on May 01

Elevation Oncology ELEV Stock Earnings Reports

Q1'25

Est.

$-0.20

Q4'24

Beat

by $0.04

Q3'24

Missed

by $0.03

Q2'24

Beat

by $0.04

Q1'24

Missed

by $0.03

The last earnings report on March 06 showed earnings per share of -18 cents, beating the estimate of -21 cents. With 2.02M shares outstanding, the current market capitalization sits at 15.51M.

View a ticker or compare two or three

Compare

ELEV